The authors discuss subjectivity in the ICH Q9 (R1) guidance document.
Amin Ziaie
Advertisement
Amin Ziaie, QRM Merck & Co., Inc, PRST, the Technological University Dublin.
Articles by Amin Ziaie
Advertisement
Latest Updated Articles
Subjectivity in Quality Risk ManagementPublished: March 15th 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
3
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5
